Maxim Group analyst Jason McCarthy downgraded Brooklyn ImmunoTherapeutics Inc. (NASDAQ: BTX) from Buy to Hold. The analyst commented:"On 10/11/22, Brooklyn ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE